DJIA 16,804.71 -238.19 -1.40%
NASDAQ 4,422.09 -71.31 -1.59%
S&P 500 1,946.16 -26.13 -1.32%
market minute promo

Novo Nordisk (NYSE: NVO)

47.82 0.20 (0.42%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVO $47.82 0.42%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.15
Previous Close $47.62
Daily Range $47.63 - $48.17
52-Week Range $32.55 - $49.11
Market Cap $131.5B
P/E Ratio 0.00
Dividend (Yield) $0.61 (1.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,169,609
Average Daily Volume 1,037,184
Current FY EPS $1.79





Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website:

News & Commentary

Why Novo Nordisk Stock Is Better Than the Best

Three reasons make Novo Nordisk a must-have company in your stock portfolio.

Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20%

3 Companies Helping To Keep Diabetes Rates Lower

Best European Stock Ideas Today: 10/01/2014

Prudential and Novo Nordisk Declines Pull Down European ADRs

Today's Stocks Driving Success For The Drugs Industry

Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog

China Biologic Presents A Unique Investment Opportunity

3 Best Stocks to Invest in Pharma

AbbVie, Novo Nordisk, and Johnson & Johnson are three top healthcare stocks poised to delight investors for years to come

Sector Update: Health-Care Shares Lower in Pre-Market Trade

See More NVO News...

NVO's Top Competitors

NVO $47.82 (0.42%)
Current stock: NVO
JNJ $104.30 (-2.15%)
Current stock: JNJ
NVS $93.22 (-0.97%)
Current stock: NVS
RHHBY $36.74 (-0.68%)
Current stock: RHHBY